LA
OACCW

Linden Advisors’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

Linden Advisors’s Portfolio OACCW Stock Details OACCW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$85.5K Hold
120,000
– – ﹤0.01% 476
2025
Q4 		$99K Hold
120,000
– – ﹤0.01% 403
2025
Q3 		$94.8K Hold
120,000
– – ﹤0.01% 349
2025
Q2 		$105K Hold
120,000
– – ﹤0.01% 315
2025
Q1 		$85.8K Buy
+120,000
New +$91.2K ﹤0.01% 245

Other funds holding OACCW

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Linden Advisors's OACCW Position: Q1 2026 in Review

Linden Advisors held its Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) position steady in Q1 2026 at 120,000 shares worth $85.5K. The position accounts for ﹤0.01% of the portfolio, ranked #476.

Linden Advisors first reported a position in OACCW in Q1 2025 and has held it in 5 quarters since. The position peaked at $105K in Q2 2025. 26 funds tracked by Wall St. Rank hold OACCW as of Q1 2026.

  • Linden Advisors held 120,000 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $85.5K as of Q1 2026.
  • Linden Advisors left its Oaktree Acquisition Corp III Life Sciences Warrant share count unchanged in Q1 2026.
  • Oaktree Acquisition Corp III Life Sciences Warrant made up ﹤0.01% of Linden Advisors's portfolio in Q1 2026, its #476 holding.
  • Linden Advisors first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q1 2025 and has held it in 5 quarters since.
  • Linden Advisors's Oaktree Acquisition Corp III Life Sciences Warrant position peaked at $105K in Q2 2025.
  • 26 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q1 2026.

Based on Linden Advisors's 13F filing for Q1 2026, filed 15 May 2026.